# Baxter International Inc: filings

BAX · NYSE · CIK 10456 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bax.md) · [Financials](/companies/bax/financials.md) · [Filings](/companies/bax/filings.md) · [Insiders](/companies/bax/insiders.md)

## Reports and events: 321 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1011, 8-K 220, 3 63, 10-Q 54, SC 13G/A 44, 425 32, 11-K 24, DEFA14A 24, 10-K 18, DEF 14A 18, UPLOAD 18, 424B2 17, SC 13G 15, SCHEDULE 13G/A 15, CORRESP 14, SD 13, NO ACT 12, FWP 11, S-8 9, PRE 14A 6, S-3ASR 6, SC 13D/A 6, SC TO-I/A 6, 3/A 5, 144 4, EFFECT 4, S-8 POS 4, SCHEDULE 13G 4, 25-NSE 3, 424B5 3, 5 3, 8-K/A 3, 15-12B 2, 424B3 2, 4/A 2, 8-A12B 2, ARS 2, PX14A6G 2, S-4 2, SC 13D 2, CERT 1, CERTNYS 1, DEFR14A 1, NT 10-K 1, NT 10-Q 1, POS AM 1, S-3 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:31 ET | [10-Q](/filings/0001628280-26-068278.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068278 |
| 2026-10-29 | 07:18 ET | [8-K](/filings/0000010456-26-000004.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000010456-26-000004 |
| 2026-08-19 | 08:07 ET | [8-K](/filings/0001193125-26-356188.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-356188 |
| 2026-08-18 | 17:00 ET | [8-K](/filings/0001628280-26-057739.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-057739 |
| 2026-08-04 | 17:22 ET | [8-K](/filings/0001193125-26-333134.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-333134 |
| 2026-08-04 | 08:32 ET | [8-K](/filings/0001628280-26-052180.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-052180 |
| 2026-07-30 | 16:45 ET | [10-Q](/filings/0001628280-26-051118.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051118 |
| 2026-07-30 | 07:17 ET | [8-K](/filings/0001628280-26-050795.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-050795 |
| 2026-07-14 | 16:15 ET | [8-K](/filings/0001628280-26-048158.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-048158 |
| 2026-05-08 | 16:16 ET | [8-K](/filings/0001193125-26-214680.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-214680 |
| 2026-04-30 | 16:50 ET | [10-Q](/filings/0001628280-26-028962.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028962 |
| 2026-04-30 | 07:17 ET | [8-K](/filings/0001628280-26-028582.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-028582 |
| 2026-03-23 | 08:51 ET | [DEF 14A](/filings/0001628280-26-020330.md) | Proxy statement, period 2026-05-05 | 0001628280-26-020330 |
| 2026-03-19 | 16:45 ET | [8-K](/filings/0001193125-26-116114.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-116114 |
| 2026-03-16 | 08:49 ET | [8-K](/filings/0001193125-26-107345.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-107345 |
| 2026-02-12 | 16:46 ET | [10-K](/filings/0001628280-26-007733.md) | Annual report, period 2025-12-31 | 0001628280-26-007733 |
| 2026-02-12 | 07:17 ET | [8-K](/filings/0001628280-26-007474.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-007474 |
| 2025-12-22 | 16:59 ET | [8-K](/filings/0000010456-25-000025.md) | 8.01 Other events | 0000010456-25-000025 |
| 2025-12-04 | 16:15 ET | [8-K](/filings/0001628280-25-055359.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-055359 |
| 2025-11-25 | 16:45 ET | [8-K](/filings/0001628280-25-054015.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-054015 |
| 2025-11-19 | 16:21 ET | [8-K](/filings/0001628280-25-053187.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-053187 |
| 2025-11-19 | 09:03 ET | [8-K](/filings/0001628280-25-053056.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-053056 |
| 2025-11-12 | 09:02 ET | [8-K](/filings/0001628280-25-051371.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-051371 |
| 2025-11-04 | 16:35 ET | [10-Q](/filings/0001628280-25-048897.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048897 |
| 2025-10-30 | 07:17 ET | [8-K](/filings/0001628280-25-047311.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-047311 |
| 2025-10-21 | 09:00 ET | [8-K](/filings/0001628280-25-045586.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-045586 |
| 2025-08-05 | 16:48 ET | [10-Q](/filings/0001628280-25-037877.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037877 |
| 2025-07-31 | 07:18 ET | [8-K](/filings/0001628280-25-036835.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036835 |
| 2025-07-07 | 08:51 ET | [8-K](/filings/0001193125-25-155902.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-155902 |
| 2025-06-12 | 08:48 ET | [8-K](/filings/0001193125-25-139604.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-139604 |
| 2025-05-08 | 16:15 ET | [8-K](/filings/0001628280-25-023809.md) | 5.07 Shareholder vote results | 0001628280-25-023809 |
| 2025-05-06 | 16:34 ET | [10-Q](/filings/0001628280-25-022727.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022727 |
| 2025-05-01 | 07:17 ET | [8-K](/filings/0001628280-25-021320.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-021320 |
| 2025-03-25 | 16:42 ET | [DEF 14A](/filings/0001628280-25-014747.md) | Proxy statement, period 2025-05-06 | 0001628280-25-014747 |
| 2025-03-14 | 08:32 ET | [8-K](/filings/0001628280-25-012724.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-012724 |
| 2025-02-21 | 17:15 ET | [10-K](/filings/0001628280-25-007201.md) | Annual report, period 2024-12-31 | 0001628280-25-007201 |
| 2025-02-20 | 07:18 ET | [8-K](/filings/0001628280-25-006558.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-006558 |
| 2025-02-06 | 16:48 ET | [8-K/A](/filings/0001628280-25-004275.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-004275 |
| 2025-02-03 | 07:38 ET | [8-K](/filings/0001193125-25-018871.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-018871 |
| 2025-02-03 | 07:19 ET | [8-K](/filings/0001628280-25-003388.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-003388 |
| 2025-01-31 | 16:58 ET | [8-K](/filings/0001628280-25-003333.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-003333 |
| 2024-11-27 | 16:29 ET | [8-K](/filings/0001628280-24-049407.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-24-049407 |
| 2024-11-22 | 16:34 ET | [8-K](/filings/0001628280-24-049002.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-049002 |
| 2024-11-12 | 16:38 ET | [10-Q](/filings/0001628280-24-047221.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047221 |
| 2024-11-08 | 07:18 ET | [8-K](/filings/0001628280-24-046501.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-046501 |
| 2024-11-07 | 08:49 ET | [8-K](/filings/0001628280-24-046016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-046016 |
| 2024-10-09 | 09:15 ET | [8-K](/filings/0001628280-24-042579.md) | 7.01 Regulation FD disclosure | 0001628280-24-042579 |
| 2024-09-30 | 08:31 ET | [8-K](/filings/0001628280-24-041545.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-041545 |
| 2024-09-09 | 09:05 ET | [8-K](/filings/0001628280-24-039784.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-039784 |
| 2024-09-03 | 16:45 ET | [8-K](/filings/0001193125-24-212145.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-212145 |

Page 1 of 7. [Older](/companies/bax/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:43 ET. No prices; not investment advice.